FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

ONEIL WILLIAM C 		2. Issuer Name and Ticker or Trading Symbol

ADVOCAT INC [ AVCA ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

1621 GALLERIA BOULEVARD 		3. Date of Earliest Transaction (MM/DD/YYYY)

3/11/2013
(Street)

BRENTWOOD, TN 37027
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   3/11/2013     M    5   A $0.00   (1) 21191   D    
Common Stock   3/12/2013     M    4   A $0.00   (1) 21195   D    
Common Stock   3/12/2013     A    333   (2) A $0.00   21528   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Dividend Equivalent Rights on 2011 Restricted Stock     (3) 3/11/2013     M         5      (3)   (3) Common Stock   5   $0.00   (1) 7.66   D    
Dividend Equivalent Rights on 2012 Restricted Stock     (4) 3/12/2013     M         4      (4)   (4) Common Stock   4   $0.00   (1) 9.28   D    
Stock Settled Stock Appreciation Right   $5.45                      (5) 6/18/2020   Common Stock   1000     1000   D    
Stock Settled Stock Appreciation Right   $2.37                      (5) 3/13/2019   Common Stock   1000     1000   D    
Stock Settled Stock Appreciation Right   $10.88                      (5) 3/14/2018   Common Stock   1000     1000   D    
Stock Settled Stock Appreciation Right   $11.59                      (5) 3/7/2017   Common Stock   1000     1000   D    
Stock Options (right to buy)   $5.44                      (6) 12/13/2015   Common Stock   5400     5400   D    

Explanation of Responses:
( 1)  Represents vesting of dividend equivalent.
( 2)  Restricted stock grant that will vest in equal parts over the first three anniversaries of the date of grant.
( 3)  These dividend equivalent rights accrued on shares of restricted stock granted on March 11, 2011 and will vest as the underlying shares vest.
( 4)  These dividend equivalent rights accrued on shares of restricted stock granted on March 12, 2012 and will vest as the underlying shares vest.
( 5)  Vests 1/3 on first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant, and 1/3 on the third anniversary of the date of grant.
( 6)  Fully exercisable as of the date hereof.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
ONEIL WILLIAM C
1621 GALLERIA BOULEVARD
BRENTWOOD, TN 37027 		X



Signatures
Jonathan D. Stanley, Attorney-in-Fact for William C. O'Neil 3/13/2013
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Diversicare Healthcare Services, Inc. (MM) (NASDAQ:AVCA)
過去 株価チャート
から 10 2024 まで 11 2024 Diversicare Healthcare Services, Inc. (MM)のチャートをもっと見るにはこちらをクリック
Diversicare Healthcare Services, Inc. (MM) (NASDAQ:AVCA)
過去 株価チャート
から 11 2023 まで 11 2024 Diversicare Healthcare Services, Inc. (MM)のチャートをもっと見るにはこちらをクリック